Trazodone | AF-1161 free base | Serotonin Receptor Antagonist

首页 / 抑制剂/激动剂 / / 5-羟色胺受体 / Trazodone

Trazodone {[allProObj[0].p_purity_real_show]}

货号：A285442 同义名： AF-1161 free base;AF-1161

Trazodone is an antidepressant of the serotonin antagonist and reuptake inhibitor (SARI) class.

Trazodone 化学结构
CAS号：19794-93-5

Trazodone 3D分子结构
CAS号：19794-93-5

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

购物车0 收藏询单

sales@ambeed.cn tech@ambeed.cn 400-920-2911 产品手册产品订购技术咨询
快速发货顺丰冷链运输，1-2 天到达

品质保证

技术支持

免费溶解

Trazodone 纯度/质量文件产品仅供科研

货号：A285442 标准纯度： {[allProObj[0].p_purity_real_show]} 产品说明书

批次查询：批次纯度: COA SDS NMR HPLC CNMR LC-MS

全球学术期刊中引用的产品: • Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]; • JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]; • BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]; • J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]; • PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]; 更多 >

5-羟色胺受体亚型比较

产品名称	5-HT ↓ ↑	5-HT1 ↓ ↑	5-HT2 ↓ ↑	5-HT3 ↓ ↑	5-HT5 ↓ ↑	5-HT6 ↓ ↑	5-HT7 ↓ ↑	其他靶点	纯度
Desvenlafaxine	++ 5-HT, Ki: 40.2 nM								98%
Lamotrigine	+ 5-HT (human platelets), IC50: 240 μM 5-HT (rat brain synaptosomes), IC50: 474 μM								98%
Venlafaxine	✔								98%
Fluvoxamine maleate	✔								99%
Iloperidone	✔								98%
Ziprasidone HCl	✔								98+%
Atomoxetine HCI	+ 5-HT, Ki: 77 nM								98%
Dapoxetine HCl	✔								97%
Trazodone	✔								98+%
Clomipramine HCl	✔								98%
Mirtazapine	✔								99+%
Escitalopram oxalate	+++ 5-HT, Ki: 0.89 nM								97%
Duloxetine	✔								98+%
Sertraline HCl	++ 5-HT, Ki: 13 nM								98%
Citalopram HBr	+++ serotonin reuptake, IC50: 1.8 nM								98%
Latrepirdine 2HCl	✔							GluR	98%
Fluoxetine HCl	✔								99.5%
Paroxetine hydrochloride	✔							AChR	97%
BMY 7378		++ 5-HT1A, pIC50: 6.4 5-HT1D, pIC50: 5.9	+ 5-HT2, pIC50: 5.5						97%
Flibanserin		+++ 5-HT1A, Ki: 1 nM	+ 5-HT2A, Ki: 49 nM						98%
LY310762		+ 5-HT1D, Ki: 249 nM							99%+
Cyclobenzaprine HCI			✔						99%
Blonanserin			+++ 5-HT2, Ki: 3.98 nM						98% HPLC
Cyproheptadine HCl			++++ 5-HT2, IC50: 0.6 nM						99+%
Olanzapine			✔						99+%
Pimavanserin hemitartrate			+++ 5-HT2A, pIC50: 8.7						99%
Ketanserin			+++ 5-HT2C (Human), Ki: 2.5 nM 5-HT2C (Rat), Ki: 50 nM						99%+
Loxapine succinate			++ 5-HT2 (human), Ki: 6.8 nM 5-HT2 (bovine), Ki: 6.6 nM						99%
Agomelatine			✔						98%
Clozapine			✔						98%
Amitriptyline			+ 5-HT2, Ki: 235 nM					SERT	98%
PRX-08066 maleate			+++ 5-HT2B, IC50: 3.4 nM						98+%
RS-127445			++++ 5-HT2B, pKi: 9.5 5-HT2B, pIC50: 10.4						99%+
Sarpogrelate HCl			++++ 5-HT2C, Kd: 1.1 nM 5-HT2A, Kd: 2.1 nM						98%
Tropisetron				✔					99%
Palonosetron				✔					98+%
Ramosetron HCl				++++ 5-HT3 receptor, Ki: 0.091 nM					98%
Ondansetron				✔					99%
Granisetron				✔					98%
Alosetron HCl				✔					98%
Ondansetron hydrochloride dihydrate				✔					98%
VUF10166				++++ 5-HT3A, Ki: 0.04 nM 5-HT3AB, Ki: 22 nM					99%+
Azasetron hydrochloride				++++ 5-HT3, IC50: 0.33 nM					98%
Asenapine maleate		+++ 5-HT1A, pKi: 8.6 5-HT1B, pKi: 8.4	++++ 5-HT2A, pKi: 9.75 5-HT2C, pKi: 10.46		+++ 5-HT5A, pKi: 8.84	++++ 5-HT6, pKi: 9.6	++++ 5-HT7, pKi: 9.94		97%
Risperidone		++ 5-HT1B, Ki: 14.9 nM 5-HT1D, Ki: 84.6 nM	++++ 5-HT2A, Ki: 61.9 nM 5-HT2C, Ki: 12 nM		+ 5-HT5A, Ki: 206 nM		++ 5-HT7, Ki: 6.6 nM		98%
SB 271046 HCl						+++ 5-HT6, pKi: 8.92			99%+
Intepirdine						++++ 5-HT6, pKi: 9.63			99%+
SB-269970 HCl							++ 5-HT7, pKi: 8.3		98+%
BRL 15572		++ 5-HT1D, pKi: 6 5-HT1B, pKi: 6.1	++ 5-HT2A, pKi: 6.6 5-HT2B, pKi: 6.2			+ 5-HT6, pKi: 5.9	+ 5-HT7, pKi: 6.3		98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Trazodone 生物活性

靶点	5-HT
描述	Trazodone is an antidepressant of the serotonin antagonist and reuptake inhibitor (SARI) class.

Trazodone 临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT02559167	Substance Use Disorder ... 展开 >> Cocaine Dependence Withdrawal From Addictive Substance; Detoxification 收起 <<	Phase 2	Recruiting	December 2019	Canada, Quebec ... 展开 >> Centre de recherche du Centre Hospitalier de l'Université de Montréal Recruiting Montreal, Quebec, Canada, H2X 0A9 Contact: Diego Arizala, M.A 514 890-8000 ext 30950 diego.arizala.chum@ssss.gouv.qc.ca Contact: Amel Zertal, MSc 514 890-8000 ext 36153 amel.zertal.chum@ssss.gouv.qc.ca 收起 <<
NCT01347541	Posttraumatic Stress Disorder	Phase 1	Unknown	April 2013	United States, Washington ... 展开 >> Harborview Medical Center Seattle, Washington, United States, 98104 收起 <<
NCT00270959	Post-Traumatic Stress Disorder	Phase 1	Unknown	December 2015	United States, Washington ... 展开 >> Harborview Medical Center Seattle, Washington, United States, 98104 收起 <<

Trazodone 参考文献

[1]Camargos EF, Louzada LL, et al. Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study. Am J Geriatr Psychiatry. 2014 Dec;22(12):1565-74.

[2]Fagiolini A, Comandini A, et al. Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs. 2012 Dec;26(12):1033-49. doi: 10.1007/s40263-012-0010-5.

Trazodone 实验方案

计算器

存储液制备

1mg

5mg

10mg

1 mM

5 mM

10 mM

2.69mL

0.54mL

0.27mL

13.45mL

2.69mL

1.34mL

26.89mL

5.38mL

2.69mL

Trazodone 技术信息

CAS号	19794-93-5
分子式	C₁₉H₂₂ClN₅O
分子量	371.864

别名	AF-1161 free base;AF-1161
运输	蓝冰

存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Inert atmosphere,Room Temperature

溶解度

DMSO: 105 mg/mL(282.36 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

动物实验配方

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT02559167	Substance Use Disorder ... 展开 >> Cocaine Dependence Withdrawal From Addictive Substance; Detoxification 收起 <<	Phase 2	Recruiting	December 2019	Canada, Quebec ... 展开 >> Centre de recherche du Centre Hospitalier de l'Université de Montréal Recruiting Montreal, Quebec, Canada, H2X 0A9 Contact: Diego Arizala, M.A 514 890-8000 ext 30950 diego.arizala.chum@ssss.gouv.qc.ca Contact: Amel Zertal, MSc 514 890-8000 ext 36153 amel.zertal.chum@ssss.gouv.qc.ca 收起 <<
NCT01347541	Posttraumatic Stress Disorder	Phase 1	Unknown	April 2013	United States, Washington ... 展开 >> Harborview Medical Center Seattle, Washington, United States, 98104 收起 <<
NCT00270959	Post-Traumatic Stress Disorder	Phase 1	Unknown	December 2015	United States, Washington ... 展开 >> Harborview Medical Center Seattle, Washington, United States, 98104 收起 <<
NCT02374567	Dementia Depr... 展开 >>ession Schizophrenia Psychosomatic Disorders Anxiety Disorders 收起 <<	Phase 3	Terminated	-	Germany ... 展开 >> Bezirkskrankenhaus Augsburg Augsburg, Germany Krankenhaus Hedwigshöhe Berlin, Germany Hannover Medical School Hannover, Germany, 30625 Asklepios Fachklinikum Lübben Lübben, Germany Asklepios Fachklinikum Teupitz Teupitz, Germany 收起 <<
NCT01030874	Orthostatic Hypotension ... 展开 >> Falls 收起 <<	Not Applicable	Completed	-	United States, Oregon ... 展开 >> VA Portland Health Care System, Portland, OR Portland, Oregon, United States, 97239 收起 <<
NCT02655354	Posttraumatic Stress Disorder ... 展开 >> Depression Alcohol-Related Disorders Suicidal Ideation Substance-Related Disorders Mild Cognitive Impairment Quality of Life Pain Wounds and Injury Brain Injuries Chronic Disease 收起 <<	Not Applicable	Recruiting	June 2019	-
NCT00707915	-		Completed	-	-
NCT00707915	Adverse Effects	Phase 4	Completed	-	Japan ... 展开 >> Minamihanno Hospital Hannou, Saitama, Japan, 357-0042 收起 <<
NCT00704860	Major Depression	Phase 4	Completed	-	Canada, Ontario ... 展开 >> University of Ottawa Institute of Mental Health Research Ottawa, Ontario, Canada, K1Z 7K4 收起 <<
NCT01943435	-		Completed	-	-
NCT02873234	-		Recruiting	May 2020	China, Beijing ... 展开 >> The Third Affiliated Hospital of Beijing University of Chinese Medicine Recruiting Beijing, Beijing, China, 100029 Contact: Wenjun Sun, MD, PHD +86 18910259376 doctorsunwenjun@126.com 收起 <<
NCT00330291	PTSD Anxiety,... 展开 >> Post Traumatic 收起 <<	Phase 2	Withdrawn(terminated due to in... 展开 >>ability to recruit subjects) 收起 <<	-	United States, New York ... 展开 >> SUNY Upstate Medical University Syracuse, New York, United States, 13210 收起 <<
NCT01857596	Hypoactive Sexual Desire Disor... 展开 >>der (DSM-IV-TR Defined) Sexual Interest/Arousal Disorder (DSM-5 Defined) 收起 <<	Phase 1 Phase 2	Completed	-	United States, Ohio ... 展开 >> Robert Taylor Segraves, MD, PhD Beachwood, Ohio, United States, 44122 Molly Katz, MD Cincinnati, Ohio, United States, 45219 收起 <<
NCT01598207	-		Completed	-	-
NCT02979964	High-risk Prescribing in Nursi... 展开 >>ng Homes 收起 <<	Not Applicable	Completed	-	Canada, Ontario ... 展开 >> Women's College Hospital Toronto, Ontario, Canada, M5S1B2 收起 <<
NCT00817011	Depression An... 展开 >>tidepressant Drug Adverse Reaction 收起 <<	Not Applicable	Unknown	March 2018	Korea, Republic of ... 展开 >> Samsung Medical Center Recruiting Kangnam, Seoul, Korea, Republic of, 135-710 Contact: DohKwan Kim Principal Investigator: Doh Kwan Kim, ph.D, M.D. 收起 <<
NCT01598207	Chest Pain	Phase 4	Completed	-	United States, Iowa ... 展开 >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 收起 <<
NCT01943435	Lumbar Spinal Stenosis	Not Applicable	Completed	-	United States, Pennsylvania ... 展开 >> UPMC Shadyside Center for Integrative Medicine Pittsburgh, Pennsylvania, United States, 15232 收起 <<
NCT01896349	Treatment Resistant Depression	Not Applicable	Unknown	November 2014	Brazil ... 展开 >> Federal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre (HCPA) Recruiting Porto Alegre, RS, Brazil, 90035-003 Contact: Lívia H Souza, MD +55 5198658701 livia.hs@terra.com.br Contact: Marcelo PA Fleck, MD, PhD +55 51 33598294 mfleck.voy@terra.com.br Sub-Investigator: Lívia H Souza, MD Principal Investigator: Marcelo PA Fleck, MD, PhD Sub-Investigator: Marco Antonio K Caldieraro, MD, MSc Sub-Investigator: Lucas Spanemberg, MD Sub-Investigator: Edgar A Vares, MD 收起 <<
NCT01651442	Insomnia Comorbid to Psychiatr... 展开 >>ic Disorder Primary Insomnia 收起 <<	Phase 4	Active, not recruiting	July 2018	United States, Colorado ... 展开 >> National Jewish Health Denver, Colorado, United States, 80206 Canada, Quebec Université Laval Quebec City, Quebec, Canada 收起 <<
NCT01764867	Major Depressive Disorder	Phase 4	Unknown	December 2014	China ... 展开 >> Shanghai Mental Health Center Recruiting Shanghai, China, 200030 Contact: Zhiguo Wu, M.D. 862134289888 ext 3528 wu_zhiguo@yahoo.com.cn Principal Investigator: Yiru Fang, Ph.D., M.D. 收起 <<
NCT00000179	Alzheimer Disease	Phase 3	Completed	-	United States, California ... 展开 >> University of California, Los Angeles Los Angeles, California, United States, 90095 University of California, San Diego San Diego, California, United States, 92093-0949 United States, Florida University of Miami Miami, Florida, United States, 33140 University of South Florida Tampa, Florida, United States, 33162 United States, Georgia Emory University Atlanta, Georgia, United States, 30329 United States, Illinois Southern Illinois University Springfield, Illinois, United States, 62702 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40536 United States, Massachusetts University of Massachusetts Worcester, Massachusetts, United States, 01665 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York New York University Medical Center New York, New York, United States, 10016 Mount Sinai Medical Center New York, New York, United States, 10029 University of Rochester Rochester, New York, United States, 14620 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44120 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97201-3098 收起 <<
NCT00788346	Use of Sleep Medications	Not Applicable	Completed	-	United States, Massachusetts ... 展开 >> Harvard Pilgrim Health Care Boston, Massachusetts, United States, 02215 收起 <<
NCT03668041	Insomnia	Phase 3	Not yet recruiting	January 9, 2023	United States, Connecticut ... 展开 >> VA Connecticut Healthcare System West Haven Campus, West Haven, CT Not yet recruiting West Haven, Connecticut, United States, 06516 Contact: Jennifer Vessicchio, LCSW-C 203-932-5711 ext 5350 jennifer.vessicchio@yale.edu Study Chair: John H. Krystal, MD 收起 <<
NCT01400165	Healthy	Phase 1	Unknown	December 2011	Canada, Ontario ... 展开 >> University of Ottawa, Institute of Mental Health Research Recruiting Ottawa, Ontario, Canada, K1Z-7K4 Contact: Franck Chenu, PharmD, PhD 613-722-6521 ext 6041 franck.chenu@rohcg.on.ca Contact: Wendy Fusee, RN 613-722-6521 ext 7828 wendy.fusee@rohcg.on.ca 收起 <<
NCT00253890	Poor Quality Sleep ... 展开 >> Opiate Addiction 收起 <<	Phase 3	Completed	-	United States, Rhode Island ... 展开 >> Butler Hospital Providence, Rhode Island, United States, 02906 收起 <<
NCT02922894	Sleep Apnea S... 展开 >>pinal Cord Injury 收起 <<	Phase 4	Recruiting	February 2021	United States, Michigan ... 展开 >> John D. Dingell VA Medical Center Recruiting Detroit, Michigan, United States, 48201 Contact: M. Safwan Badr, MD 313-576-3548 收起 <<
NCT00253890	-		Completed	-	-
NCT02458469	Spinal Cord Injury ... 展开 >> Sleep Disordered Breathing 收起 <<	Phase 2	Recruiting	April 1, 2019	United States, Michigan ... 展开 >> John D. Dingell VA Medical Center, Detroit, MI Recruiting Detroit, Michigan, United States, 48201 Contact: Abdulghani Sankari, MD PhD 313-576-1000 ext 63499 Abdulghani.Sankari@va.gov Principal Investigator: Abdulghani Sankari, MD PhD 收起 <<
NCT03534284	Insomnia End ... 展开 >>Stage Renal Disease 收起 <<	Phase 3	Recruiting	August 2021	United States, Washington ... 展开 >> Northwest Kidney Centers Recruiting Seattle, Washington, United States, 98122 Contact: Lori Linke, BA 206-720-3835 llinke@nephrology.washington.edu Contact: Carlyn Clark, MSW 206-720-8811 cclark@nephrology.washington.edu 收起 <<
NCT00027053	Alcoholism	Phase 2	Completed	-	United States, Rhode Island ... 展开 >> Rhode Island Hospital Providence, Rhode Island, United States, 02903 收起 <<
NCT02699138	Sleep Apnea, Obstructive; Post... 展开 >>-Traumatic Stress Disorders 收起 <<	Early Phase 1	Suspended(Research fellow left... 展开 >> institution) 收起 <<	December 2019	United States, California ... 展开 >> University of California San Diego San Diego, California, United States, 92103 收起 <<
NCT01468038	Sleep Disorder	Phase 3	Completed	-	United States, California ... 展开 >> Targeted Medical Pharma Los Angeles, California, United States, 90077 收起 <<
NCT03749642	Painful Diabetic Neuropathy	Phase 2	Not yet recruiting	December 2020	-
NCT02118688	Delirium Agit... 展开 >>ation 收起 <<	Phase 4	Terminated(Lack of enrollment)	March 2016	United States, New York ... 展开 >> Rochester General Hospital Rochester, New York, United States, 14621 收起 <<
NCT00775203	Major Depressive Disorder	Phase 3	Completed	-	-
NCT00659919	Schizophrenia	Phase 4	Completed	-	Israel ... 展开 >> Beer Yaakov MHC Beer Yaacov, Israel, 70350 收起 <<
NCT01348542	Insomnia	Not Applicable	Active, not recruiting	June 2018	United States, Pennsylvania ... 展开 >> Penn State College of Medicine, Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 收起 <<
NCT01817907	Sleep Apnea, Obstructive	Not Applicable	Completed	-	United States, Massachusetts ... 展开 >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 收起 <<
NCT00791739	Fibromyalgia	Phase 4	Completed	-	Spain ... 展开 >> Instituto de Neurociencias Granada, Spain, 18012 收起 <<
NCT02785614	Depression	Phase 1	Completed	-	Hong Kong ... 展开 >> Phase I Clinical Trial Centre, Chinese University of Hong Kong Hong Kong, Sha Tin New Territories, Hong Kong, 000000 收起 <<
NCT00775203	-		Completed	-	-
NCT02785601	Depression	Phase 1	Completed	-	Hong Kong ... 展开 >> Prince of Wales Hospital Hong Kong, Hong Kong 收起 <<
NCT01817907	-		Completed	-	-
NCT01524497	Depression	Phase 2 Phase 3	Completed	-	China, Hunan ... 展开 >> The Second Xiangya Hospital of Central South University Changsha, Hunan, China, 410011 收起 <<
NCT01142258	Sleep Sleep D... 展开 >>isorders Insomnia Alzheimer's Disease 收起 <<	Phase 3	Completed	-	Brazil ... 展开 >> Geriatric Medical Centre Brasilia, Distrito Federal, Brazil 收起 <<
NCT03522207	TMD Sleep Bru... 展开 >>xism TMJ Pain Chronic Pain Sleep Disorder 收起 <<	Phase 4	Not yet recruiting	May 2020	-
NCT01121913	Healthy	Phase 1	Completed	-	-
NCT03516630	Healthy	Phase 1	Completed	-	Switzerland ... 展开 >> CROSS Research S.A., Phase I Unit, Arzo, Switzerland, CH-6864 收起 <<
NCT01121926	Healthy Subjects ... 展开 >> Bioavailability Pharmacokinetics 收起 <<	Phase 1	Completed	-	-
NCT02086929	Major Depressive Disorder	Phase 3	Completed	-	Austria ... 展开 >> Institute für Psychosomatik Vienna, Austria, 1010 AKH Wien Vienna, Austria, 1090 Czech Republic PRAGTIS, s.r.o. Praha 2, Praha, Czech Republic, 12000 Psychiatry Trial, s.r.o. Praha 5, Praha, Czech Republic, 15800 MEDICAL SERVICES PRAGUE, s.r.o. Praha 6, Praha, Czech Republic, 160 00 Neuropsychiatrie s.r.o. Praha 6, Praha, Czech Republic, 160 00 Saint Anne, s.r.o. Brno-mesto, Czech Republic, 60200 SUPERVIZE, s.r.o. Kutna Hora, Czech Republic, 284 01 BIALBI s.r.o. Litomerice, Czech Republic, 41201 Fakultni Nemocnice Olomouc, Klinika Psychiatrie Olomouc, Czech Republic, 77 900 MUDr. Eva Soukupová-Psychiatrická praxe, s.r.o. Plzeň, Czech Republic, 301 00 NZZ- MUDr. Jaroslav Hronek, psychiatrická ambulance Plzeň, Czech Republic, 301 00 Italy UOPI di Psichiatria Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele, Presidio "Gaspare Rodolico" Catania, Italy, 95100 Clinica Psichiatrica Nuovo Ospedale S. Salvatore Università degli Studi del L'Aquila L'Aquila, Italy, 67100 Ospedale Santa Maria della Misericordia Unità di Degenza Psichiatrica-SPDC Perugia, Italy, 06132 Azienda Ospedaliera Sant'Andrea Università La Sapienza Unità Operativa Complessa di Psichiatria Rome, Italy, 00189 AOUS-Azienda Ospedaliera Universitaria Senese Policlinico Santa Maria alle Scotte Clinica Psichiatrica Universitaria Siena, Italy, 53100 Department of Neurosciences University of Turin Turin, Italy, 10126 Romania Quantum Medical Center Srl Bucharest, Romania, RO-011426 Spitalul clinic de psihiatrie "Prof. Dr. Al. Obregia"/Sectia 13 Bucharest, Romania, RO-041914 Spitalul Clinic de Psihiatrie "Prof. Dr. Al. Obregia"/Sectia 1 Bucharest, Romania, RO-041914 Spitalul Clinc de Urgenta Militar "Dr. Stefan Odobleja", Craiova Craiova, Romania, RO-200530 Spital Clinic de Psihiatrie SOCOLA / Iasi Iasi, Romania, RO-700282 Spitalul de Psihiatrie "Dr. Gh.Preda" Sibiu Sibiu, Romania, RO-550082 Spitalul Clinc Judetean Mures, Centrul de Sanatate Mintala Targu Mures, Romania, RO-540096 Slovakia Psychiatricka ambulancia Bratislava, Slovakia, 81107 MENTUM, s.r.o. Bratislava, Slovakia, 82007 EPAMED, s.r.o. Kosice, Slovakia, 4000 Psychiatricka nemocnica Michalovce, Slovakia, 7101 Psycholine, s.r.o. Rimavska Sobota, Slovakia, 97901 Psychiatricke oddelenie, NsP sv Barbory Roznava Roznava, Slovakia, 4801 Spain Instituto de Investigacion y Asistencia Psiquiatrica - IIAP Madrid, Spain, 28002 收起 <<
NCT01121900	Healthy	Phase 1	Completed	-	-
NCT01121913	-		Completed	-	-
NCT00839072	Healthy	Phase 1	Completed	-	Canada, Quebec ... 展开 >> Algorithme Pharma Inc. Laval, Quebec, Canada, H7V 4B3 收起 <<
NCT01121926	-		Completed	-	-
NCT01097980	Sexual Dysfunction	Not Applicable	Completed	-	Taiwan ... 展开 >> Department of Psychiatry, Beitou Armed Forces Hospital Taipei, Taiwan, 11243 收起 <<
NCT01121900	-		Completed	-	-
NCT00839072	-		Completed	-	-
NCT01662297	Insomnia Ment... 展开 >>al Health Disorder Substance Use Disorder 收起 <<	Phase 4	Terminated(it became clear tha... 展开 >>t recruitment was infeasible) 收起 <<	-	United States, Connecticut ... 展开 >> VA Connecticut Healthcare System West Haven, Connecticut, United States, 06516 收起 <<
NCT03202979	Painful Diabetic Neuropathy	Phase 2	Completed	-	Czechia ... 展开 >> NEUROHK s.r.o. Chocen, Czechia, 565 01 Litnea s.r.o. Neurologicka ambulance Litomerice, Czechia, 412 01 Neurosanatio s.r.o. Litomysl, Czechia, 570 01 MP-neuro s.r.o. Poliklinika Modry pavilon Ostrava, Czechia, 710 00 Nemocnice Pardubickeho kraje a.s. Pardubicka nemocnice Neurologická klinika Pardubice, Czechia, 532 03 Diabetologicka ambulance Milan Kvapil s.r.o. Praha 4, Czechia, 149 00 Vestra Clinics s.r.o. Rychnov nad Knežnou, Czechia, 516 01 Hungary Budai Irgalmasrendi Korhaz Belgyógyászati Centrum Budapest, Hungary, 1027 Semmelweis Egyetem AOK I. sz. Belgyogyaszati Klinika Budapest, Hungary, 1083 Markhot Ferenc Oktatokorhaz es Rendelointezet Diabetesz Gondozo Eger, Hungary, 3300 Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz I. sz. Belgyogyaszati Osztaly Gyula, Hungary, 5700 Bacs-Kiskun Megyei Korhaz II. sz. Belgyogyaszati Osztaly Kecskemet, Hungary, 6000 Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont I. Sz. Belgyogyaszati Klinika Szeged, Hungary, 6720 Poland Silmedic Sp. z o.o. Katowice, Poland, 40-282 Pro Familia Altera Sp. z o.o. Katowice, Poland, 40-648 NZOZ Neuromed M. i M. Nastaj Sp. P. Lublin, Poland, 20-064 RCMed Oddział Sochaczew Sochaczew, Poland, 96-500 Jeka Sławomir Niepubliczny Zakład Opieki Zdrowotnej "Nasz Lekarz" Praktyka Grupowa Lekarzy Rodzinnych z Przychodnia Specjalistyczna Torun, Poland, 87-100 NBR Polska Tomasz Klodawski Warszawa, Poland, 00-465 Medycyna Kliniczna Warszawa, Poland, 00-660 收起 <<
NCT01662297	-		Terminated(it became clear tha... 展开 >>t recruitment was infeasible) 收起 <<	-	-
NCT02945644	Sleep Apnea, Obstructive	Phase 1	Recruiting	December 2017	United States, Ohio ... 展开 >> Louis Stokes Cleveland VA Medical Center Recruiting Cleveland, Ohio, United States, 44106 Contact: Kingman P Strohl, MD 201-402-1453 kingman.strohl@va.gov Contact: Anna M May, MD 216-408-0048 drannamay@gmail.com 收起 <<

Trazodone {[allProObj[0].p_purity_real_show]}

Trazodone 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Trazodone 质控信息

Trazodone 生物活性

Trazodone 临床研究

Trazodone 参考文献

Trazodone 实验方案

Trazodone 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Trazodone {[allProObj[0].p_purity_real_show]}

Trazodone 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Trazodone 质控信息

Trazodone 生物活性

Trazodone 临床研究

Trazodone 参考文献

Trazodone 实验方案

Trazodone 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Trazodone 纯度/质量文件产品仅供科研